As of January 1, 2024, 51 percent of phase II clinical trials in the Alzheimer’s disease drug development pipeline were located in North America (U.S. & Canada) only, while the percentage was at 29 percent for phase III clinical trials targeting this disease.
Share of phase II and III trials targeting the Alzheimer’s disease as of 2024, by location
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Alzheimer's Association. (April 24, 2024). Share of phase II and III trials targeting the Alzheimer’s disease as of 2024, by location [Graph]. In Statista. Retrieved November 22, 2024, from https://www.statista.com/statistics/1173719/location-sites-for-phase-2-and-3-trials-for-alzheimer-disease-by-location/
Alzheimer's Association. "Share of phase II and III trials targeting the Alzheimer’s disease as of 2024, by location." Chart. April 24, 2024. Statista. Accessed November 22, 2024. https://www.statista.com/statistics/1173719/location-sites-for-phase-2-and-3-trials-for-alzheimer-disease-by-location/
Alzheimer's Association. (2024). Share of phase II and III trials targeting the Alzheimer’s disease as of 2024, by location. Statista. Statista Inc.. Accessed: November 22, 2024. https://www.statista.com/statistics/1173719/location-sites-for-phase-2-and-3-trials-for-alzheimer-disease-by-location/
Alzheimer's Association. "Share of Phase Ii and Iii Trials Targeting The Alzheimer’s Disease as of 2024, by Location." Statista, Statista Inc., 24 Apr 2024, https://www.statista.com/statistics/1173719/location-sites-for-phase-2-and-3-trials-for-alzheimer-disease-by-location/
Alzheimer's Association, Share of phase II and III trials targeting the Alzheimer’s disease as of 2024, by location Statista, https://www.statista.com/statistics/1173719/location-sites-for-phase-2-and-3-trials-for-alzheimer-disease-by-location/ (last visited November 22, 2024)
Share of phase II and III trials targeting the Alzheimer’s disease as of 2024, by location [Graph], Alzheimer's Association, April 24, 2024. [Online]. Available: https://www.statista.com/statistics/1173719/location-sites-for-phase-2-and-3-trials-for-alzheimer-disease-by-location/
